Loading viewer...
investor_presentation
Format: PDF investor_presentation
This corporate presentation by RNXT outlines their late-clinical stage biopharmaceutical developments, focusing on pancreatic cancer therapies and future strategies.
investor_presentation
15 Pages
WiSA Technologies, Inc.
Luminar Technologies Business Overview 2020
investor_presentationinvestor_presentation
42 Pages
Luminar Technologies, Inc.